Validation of Major Adverse Cardiovascular Events (MACE) in US Claims Databases

被引：0

作者：

Haynes, Kevin ^{[1
]}

Nezamzadeh, Melissa S. ^{[1
]}

Newcomb, Craig W. ^{[1
]}

Roy, Jason ^{[1
]}

Kite, Whitney ^{[1
]}

Carbonari, Dena M. ^{[1
]}

Cardillo, Serena ^{[1
]}

Hennessy, Sean ^{[1
]}

Freeman, Cristin P. ^{[1
]}

Holick, Crystal N. ^{[2
]}

Esposito, Daina B. ^{[2
]}

Strom, Brian L. ^{[3
]}

Vincent, Lo Re ^{[1
]}

机构：

[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA

[2] HealthCore, Wilmington, DE USA

[3] Rutgers State Univ, Rutgers Biomed & Hlth Sci, New Brunswick, NJ 08903 USA

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

734

引用

页码：394 / 395

页数：2

共 50 条

[31] Rates of major adverse cardiovascular events (MACE) and revascularization among patients with psoriasis or psoriatic arthritis treated with apremilast, biologics, DMARDs, and corticosteroids in the US MarketScan database
Persson, Rebecca
Hagberg, Katrina W.
Qian, Ellen
Vasilakis-Scaramozza, Catherine
Niemcryk, Steve
Peng, Michael
Paris, Maria
Lindholm, Anders
Jick, Susan
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 474 - 474
[32] Increased major adverse cardiovascular events (MACE) in deceased donor liver transplant recipients as compared to living donor recipients
Futeran, Hannah
Loza, Bao-Li
Bittermann, Therese
Olthoff, Kim
Shaked, Oren
AMERICAN JOURNAL OF TRANSPLANTATION, 2025, 25 (01)
[33] Prediabetes and the Incidence of Major Adverse Cardiovascular Events
Booth, Gillian L.
Rezai, Mohammad R.
Atzema, Clare
Austin, Peter C.
Bhatia, Sacha
Bierman, Arlene S.
Clemens, Kristin K.
Johnston, Sharon
Ko, Dennis T.
Lee, Douglas S.
Tu, Karen
Tu, Jack V.
DIABETES, 2017, 66 : A81 - A82
[34] RISK FACTORS FOR MAJOR ADVERSE CARDIOVASCULAR (CV) EVENTS (MACE) IN RHEUMATOID ARTHRITIS (RA) PATIENTS TREATED WITH TOCILIZUMAB (TCZ)
Rao, V. U.
Pavlov, A.
Klearman, M.
Musselman, D.
Giles, J. T.
Bathon, J. M.
Sattar, N.
Lee, J. S.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 356 - 357
[35] Major Adverse Cardiovascular Events (MACE) following partial nephrectomy: PN-A4CH a novel risk index
Nasrallah, A. A.
Dakik, H.
Abou Heidar, N.
Nasrallah, O.
Najdi, J.
Mansour, M.
Tamim, H.
El Hajj, A.
EUROPEAN UROLOGY, 2021, 79 : S854 - S855
[36] Rates of Major Adverse Cardiovascular (CV) Events (MACE) and Mortality with Basal Insulin by Liraglutide Use-A DEVOTE Subanalysis
Brown-Frandsen, Kirstine
Emerson, Scott S.
Marso, Steven P.
Mcguire, Darren K.
Pieber, Thomas R.
Poulter, Neil R.
Zinman, Bernard
Gron, Randi
Lange, Martin
Moses, Alan C.
Orsy, Petra
Ranthe, Mattis F.
Pratley, Richard E.
DIABETES, 2018, 67
[37] Biological Therapies for Psoriasis and Psoriatic Arthritis- effects on Future Risk Development of Major Adverse Cardiovascular Events (MACE)
Dotan, Arad
Ben-Shabbat, Niv
Watad, Abdulla
McGonagle, Dennis
Amital, Howard
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 969 - 971
[38] MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) AFTER KIDNEY TRANSPLANTATION: A POPULATION-COHORT ANALYSIS OF ENGLISH TRANSPLANT CENTRES
Anderson, Benjamin
Evison, Felicity
Gallier, Suzy
Ferro, Charles
Sharif, Adnan
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 251 - 251
[39] Epicardial adipose tissue (EAT) volume is related to subclinical atherosclerosis and major adverse cardiovascular events (MACE) in asymptomatic subjects
Sousa, A.
Mendonca, M. I.
Santos, M.
Temtem, M.
Mendonca, F.
Sousa, A. C.
Rodrigues, M.
Freitas, S.
Henriques, E.
Borges, S.
Guerra, G.
Drumond, A.
Palma Dos Reis, R.
EUROPEAN HEART JOURNAL, 2021, 42 : 2509 - 2509
[40] MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) AFTER KIDNEY TRANSPLANTATION: A POPULATION-COHORT ANALYSIS OF ENGLISH TRANSPLANT CENTRES
Anderson, Benjamin
Evison, Felicity
Gallier, Suzy
Sharif, Adnan
TRANSPLANT INTERNATIONAL, 2021, 34 : 45 - 46

← 1 2 3 4 5 →